Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.


TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Telehealth and Telemedicine............SZLS
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(435)
•••
Comment by Oilersgoforcupon Jan 13, 2021 2:29pm
147 Views
Post# 32286587

RE:Telehealth and Telemedicine............SZLS

RE:Telehealth and Telemedicine............SZLSAs the COVID-19 pandemic has begun to show measurable signs of a second wave around the world, it has created a potential $250 billion market opportunity, according to a new report filed by a US-based management consulting firm.

McKinsey & Co. analysts estimate that up to 20% of all Medicare, Medicaid, and commercial outpatient, office, and home health spend could be done virtually.

In the report released on Wednesday, it noted that recent acquisitions and support from the US federal government in the form of an executive order to expand telehealth in rural areas, the telehealth boom has just begun to revolutionize the multi-trillion-dollar healthcare market.

More people are embracing telehealth for their medical needs. Upwards of 60% of Medicare-age seniors say they are using the technology in some form, according to a recent survey from healthinsurance.com.


SZLS>>>>PRIME TARGET FOR ACQUISITION>>>>>
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities